Similar Items: Short‐term psychological impacts of Alzheimer's disease risk disclosure based on blood‐biomarker results
- CSF Biomarkers of Alzheimer’s Disease: Impact on Disease Concept, Diagnosis, and Clinical Trial Design
- Heritability of Alzheimer's disease–related plasma biomarkers in the Amish population
- APOE ε4 and Alzheimer's disease biomarkers in an American Indian community
- A fovea‐centered retinal signature linked to plasma biomarkers in prodromal Alzheimer's disease
- Simulation of long‐term lecanemab treatment effect on Alzheimer's disease progression
- Perceptions of the use of biomarkers for Alzheimer's disease diagnosis: A systematic review and synthesis of the qualitative literature